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Abstract
Background: Curable, non-viral pathogens account for a significant burden of sexually transmitted infections (STIs), and
there is established evidence that STIs increase both HIV acquisition and transmission. We investigated the prevalence,
trends, and factors associated with Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Treponema
pallidum, and the performance of syndromic management, among a cohort of women working in bars, hotels, and other
food and recreational facilities near large-scale mines in northwestern Tanzania.
Methods: HIV-negative women aged 18–44 years (N = 966) were enrolled and followed for 12 months in a microbicides
feasibility study. We collected sociodemographic and behavioural data, performed clinical examinations, and tested for STIs,
at enrolment and 3-monthly. Risk factors for STIs were investigated using logistic regression models with random effects.
Sensitivity, specificity and predictive values of syndromic management were calculated.
Results: At enrolment, the prevalences of C. trachomatis, N. gonorrhoeae, T. vaginalis, and high-titre active syphilis were 111/
956 (12%), 42/955 (4%), 184/945 (19%) and 46/965 (5%), respectively. There were significant decreases over time for C.
trachomatis and T. vaginalis (OR trend per month: 0.94 [95% CI 0.91, 0.97]; and 0.95 [0.93, 0.98], respectively; both p,0.001).
The majority of these infections were not diagnosed by the corresponding syndrome; therefore, most participants were not
treated at the diagnosis visit. Syndromic management was poorly predictive of laboratory-diagnosed infections. We
identified a number of risk factors for STIs, including low educational level, some sexual behaviours, and ever having been
pregnant.
Conclusions: This analysis demonstrates that the prevalences of curable STIs are high among women who work in food and
recreational facilities in northwestern Tanzania. Most of these infections are missed by syndromic management. Accurate
and affordable rapid-point-of-care tests and innovative interventions are needed to reduce the burden of STIs in this
population which is at increased risk for HIV.
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Introduction
Despite steady advances in diagnosis, treatment, and public
health interventions, sexually transmitted infections (STIs) contin-
ue to affect a large proportion of those living in resource-limited
settings, particularly women of reproductive age [1]. Curable,
non-viral pathogens (including Chlamydia trachomatis, Neisseria
gonorrhoeae, Trichomonas vaginalis and Treponema pallidum) account
for a significant burden of STIs [2]. There is established evidence
that STIs increase both HIV acquisition and transmission [3–5].
Furthermore, untreated infections can lead to adverse reproduc-
tive health outcomes including pelvic inflammatory disease,
infertility, premature labour, low birth weight, and congenital
infections [6–8].
Women working in bars, hotels and other food and recreational
facilities in Tanzania have been documented to have higher risk of
STIs, including HIV, than the general population [9–12]. Studies
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in similar populations in Mbeya, Moshi, Mwanza city, and
Mwanza region, Tanzania, reported prevalences of 6–13% for C.
trachomatis, 4–22% for N. gonorrhoeae, 12–24% for T. vaginalis, and
8–24% for active infection with T. pallidum (i.e. active syphilis)
[9,10,12,13]. The Tanzanian Ministry of Health advocates
syndromic management of STIs [14]. Syndromic management is
based on the identification of a syndrome (a group of symptoms
and easily recognised signs), and the provision of treatment
targeting the organisms mainly responsible for causing the
syndrome [15]. However, several recent papers have reported
relatively poor performance of this approach among women due
to most infections being asymptomatic [16,17]. Better knowledge
of the epidemiology of STIs among women who are most
vulnerable to these infections may lead to improved treatment
policies and prevention programmes to reduce their burden and
mitigate subsequent reproductive health problems.
In this report, we aim to describe the prevalence, trends and risk
factors of curable, non-viral STIs among women at increased risk
for HIV infection in northwestern Tanzania who participated in a
12 month prospective cohort study designed to assess feasibility for
conducting future microbicide trials. The background HIV
prevalence in this population is 16%, and data on viral infections
including HIV-1 and Herpes simplex virus 2 (HSV-2) have been
reported elsewhere [18].
Methods
Ethical statement
The study was approved by the Ethics Committees of the
National Institute for Medical Research and London School of
Hygiene and Tropical Medicine. All participants gave written
informed consent. Participants’ confidentiality was ensured by
excluding personal identification (such as names) from forms used
to collect study information and by storing study documents and
samples in a secure location. Study staff members were trained on
issues of confidentiality, good clinical practice, research ethics and
protection of human subjects.
Study procedures
HIV-1 seronegative, non-pregnant women aged 18–44 years
working in bars, hotels, and other food and recreational facilities in
the three towns of Geita, Shinyanga and Kahama in northwestern
Tanzania were recruited into a 12 month microbicide feasibility
study in 2008–2010. These towns are located near large-scale gold
or diamond mines in which there are large populations of
migratory male workers. The study population, inclusion criteria
and procedures have been detailed previously [18]. Following the
informed consent process, a face-to-face interview was conducted
to elicit information on sociodemographic characteristics, sexual
behaviour, contraceptive use, alcohol use and genital symptoms.
Each participant was examined and samples for STIs and other
reproductive tract infections (RTIs) were obtained, including a
posterior fornix vaginal swab for T. vaginalis culture, a high lateral
vaginal swab for assessing the vaginal microbiota (e.g. bacterial
vaginosis), and a cervical swab for detection of C. trachomatis and N.
gonorrhoeae. A blood sample was collected for testing for syphilis,
HIV, and HSV-2, and a urine sample for pregnancy testing.
Participants diagnosed with pelvic inflammatory disease (PID),
vaginal discharge syndrome (VDS), or genital ulcer disease (GUD)
were treated according to Tanzanian Ministry of Health
syndromic STI management guidelines [14]. Participants were
asked to return every three months for one year for a total of five
visits. At follow-up visits, similar procedures were conducted with a
face-to-face interview, gynaecological examination and blood
draw for HIV and syphilis. However, testing for C. trachomatis, N.
gonorrhoeae, T. vaginalis and HSV-2 was done only at enrolment and
months six and 12.
If the participant had not previously been treated by syndromic
management and had a positive laboratory test for C. trachomatis, N.
gonorrhoeae, T. vaginalis or syphilis, they were traced and treated for
the infection between study visits.
Laboratory methods
Serum samples were tested for syphilis, HIV and HSV-2.
Syphilis was diagnosed using a semi-quantitative RPR test
(Immutrep Carbon Antigen, Omega Diagnostics, Alva, Scotland)
and the Treponema pallidum particle agglutination assay (TPPA)
(SERODIA, Fujirebio Inc., Tokyo, Japan). At enrolment, partic-
ipants who were TPPA-positive and RPR-positive were considered
to be prevalent cases of active syphilis, and participants who were
TPPA-positive and had an RPR titre of at least 1:8 were
considered to have high-titre active syphilis. An incident case of
syphilis was defined as follows: participants who were previously
TPPA-negative and were TPPA-positive at a follow-up visit; or
participants who were previously TPPA-positive and had a two-
fold increase in RPR titre (to a titre of at least 1:8) at a follow-up
visit. HIV testing was performed in parallel using third generation
Murex HIV 1.2.O (Abbott UK, Dartford, Kent, England) and
Vironostika HIV Uniform II plus O (bioMerieux Bv, The
Netherlands) enzyme-linked immunosorbent assays (ELISAs).
Samples discrepant or indeterminate on ELISA were tested for
P24 Antigen (Genetics Systems HIV-1 Ag EIA, Bio-rad Labora-
tories, Marnes-la-Coquette, France) and if positive were classified
as HIV-positive. Samples negative for P24 antigen were tested by
Western Blot (INNO-LIA, HIV I/II score, Innogenetics NV,
Gent, Belgium). HSV-2 was detected using type-specific IgG
ELISA (Kalon Biologicals Ltd., Guildford, UK.
A cotton-tipped swab was collected from the posterior fornix of
the vagina for culture of T. vaginalis (InPouch, BioMed Diagnostics,
San Jose, CA, USA), incubated at 36–37uC and read every
24 hours for 72 hours. Dacron swabs were collected from the
endocervix and tested for C. trachomatis and N. gonorrhoeae by PCR
(AMPLICOR, Roche Diagnostics, Branchburg, NJ, USA). All
positive tests for N. gonorrhoeae were confirmed using specific
primers to the 16S rDNA coding region using PCR in-house
assays [19]. Vaginal microbiota were evaluated by microscopy of a
Gram-stained vaginal smear using Nugent criteria which defines
normal microbiota (scores 0–3), intermediate microbiota (scores 4–
6) and bacterial vaginosis (scores 7–10) [20]. Candidiasis was
diagnosed by wet mount microscopy.
Statistical methods
Questionnaires were reviewed at site for completeness and
consistency, and transported to a central data management centre.
Double data entry was performed using DMSys software
(SigmaSoft International, Chicago, IL, USA). Analysis was
performed using Stata 11 (StataCorp, College Station, TX, USA).
Prevalence of infections and syndromes were calculated, and
95% confidence intervals were derived using Wilson’s formula
[21]. Odds ratio trends for C. trachomatis, N. gonorrhoeae, T. vaginalis
and syndromes were estimated using logistic regression with
random effects to account for repeated visits and within-women
clustering. There were few incident syphilis cases (36 cases of
incident syphilis; incidence rate was 4.8 (95% CI 3.5, 6.7) per 100
women-years), and we therefore restricted our analyses to
prevalent high-titre active syphilis at enrolment only. Sensitivity,
specificity and predictive values of PID and VDS (without curd-
like discharge) for the detection of laboratory diagnosed STIs were
Curable STIs in Northwestern Tanzania
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calculated. We did not calculate the sensitivity, specificity and
predictive values of GUD for the detection of syphilis as GUD can
be caused by syphilis, but also by herpes, chancroid and
lymphogranuloma venereum, and because serological syphilis
may not always indicate a current active infection. Concurrent
partnerships were defined as having more than one partner in the
last three months.
We investigated associations with sociodemographic, behav-
ioural and biological factors, over all visits using logistic regression
with random effects for C. trachomatis, N. gonorrhoeae and T. vaginalis,
and at enrolment using logistic regression for high-titre active
syphilis. We adjusted a priori for visit month, town and age in all
models. We built a multivariable model using a conceptual
framework with three levels (sociodemographic, behavioural and
biological). First, sociodemographic factors whose town- and age-
adjusted associations were significant at p,0.10 were included in a
multivariable model; stepwise backward selection (remove if p.
0.05; re-enter if p,0.05), to remove those no longer independently
associated, yielded our first core model. Second, behavioural
factors were added to this core model one by one; those that were
associated with the outcome at p,0.10, after adjusting for
sociodemographic factors, were included in a multivariable model
and stepwise backward selection (same criteria as above) was
applied to the behavioural variables to yield our second core
model. Third, biological factors were assessed in a similar way
(third core model). We present results at each level of the
framework, adjusted for more distal variables. Behavioural and
biological factors which were measured at each visit were
incorporated in a time-dependent manner, with the values at
each visit included to assess the associations with the STIs at the
same visit.
Results
We enrolled 966 women (375 Geita, 306 Kahama, 285
Shinyanga) of median age 26 years (interquartile range: 22, 32
years). Only 121 (13%) women had progressed to secondary
education, 428 (44%) worked as waitresses, 433 (46%) had been at
their current facility for one year or less, 432 (45%) reported that
they had ever engaged in transactional sex, 216 (24%) had
concurrent partners, 84 (9%) were using oral contraceptives, and
136 (14%) were using the injectable contraceptive depot medrox-
yprogesterone acetate (DMPA). The proportions of women who
attended visits at months 3, 6, 9 and 12 were 79%, 75%, 76% and
84%, respectively.
Prevalence of laboratory diagnosed curable STIs
At enrolment, the prevalences of C. trachomatis, N. gonorrhoeae,
and T. vaginalis were 111/956 (12%), 42/955 (4%), and 184/945
(19%), respectively. The prevalence of active syphilis was 87/965
(9%) and the prevalence of high-titre active syphilis was 46/965
(5%). Overall, 313/939 (33%) women had at least one of these
four STIs. The majority of these infections were not diagnosed
with the corresponding syndrome and therefore most participants
were not treated at enrolment. Figure 1 shows the curable STI
prevalences by visit, illustrating the study design in which syphilis
was tested for at every visit and C. trachomatis, N. gonorrhoeae, and T.
vaginalis were tested for at enrolment, six and 12 months only.
There were significant decreases over the follow-up period in the
prevalence of C. trachomatis and T. vaginalis (odds ratio [OR] test for
linear trend per month 0.94 [95% confidence interval [CI] 0.91,
0.97] and 0.95 [0.93, 0.98], respectively; both p,0.001) (Table 1).
Prevalence and performance of STI Syndromes
During the enrolment clinical interview, 539/962 (56%)
participants reported genitourinary complaints, among whom
itching was the most common complaint (64%), followed by
abdominal pain during sexual intercourse (46%), vulvar burning
(36%), dysuria (27%), abnormal vaginal discharge (25%) and
genital ulcers or blisters (12%). On the enrolment genital
examination, 500/956 (52%) participants had one or more clinical
signs suggestive of an STI. The most common syndromic diagnosis
was PID (26%), followed by VDS without curd-like discharge
(11%), VDS with curd-like discharge (10%), and GUD (6%). At
enrolment, 634 (66%) were negative for both PID and VDS
(without curd-like discharge). Figure 2 shows the prevalence of
syndromes by visit. There were significant decreases over the
follow-up period for all syndromes (OR test for linear trend per
month for PID=0.85 [95% CI 0.83, 0.88], VDS without curd-like
discharge 0.91 [0.88, 0.94], VDS with curd-like discharge 0.95
[0.92, 0.98] and GUD 0.87 [0.83, 0.91]; all p,0.001; Table 1).
Table 2 shows the sensitivity, specificity, and predictive values of
syndromic management guidelines for PID and VDS (without
curd-like discharge). The sensitivity and specificity of a PID
diagnosis to detect C. trachomatis, N. gonorrhoeae, or bacterial
vaginosis were 17% and 85%, respectively (similar results for
each infection alone). The positive predictive value (PPV) of PID
was low for C. trachomatis and N. gonorrhoeae, 12%, and 6%
respectively, and higher for bacterial vaginosis, 49%. The negative
predictive value (NPV) was high for C. trachomatis and N. gonorrhoeae,
93% and 96% respectively, and relatively lower for bacterial
vaginosis, 55%. The sensitivity and specificity of VDS to detect C.
trachomatis, N. gonorrhoeae, T. vaginalis or bacterial vaginosis were 9%
and 94%, respectively (similar results for each infection alone).
The PPV and NPV of VDS ranged from 7% and 96%,
respectively, to 66% and 41%, respectively, for all four infections
combined. The sensitivity, specificity, PPV and NPV of PID or
VDS to detect either C. trachomatis or N. gonorrhoeae were 32%, 77%,
15%, and 90% respectively.
Low PPV meant that many participants were treated with
antibiotics without an infection subsequently confirmed by
laboratory diagnosis. Of the visits at which doxycycline (treatment
for VDS and PID) or erythromycin (treatment for VDS and PID if
pregnant) were prescribed, 809/904 (89%) did not have a
laboratory diagnosis for C. trachomatis. Of the visits at which
ciprofloxacin (treatment for VDS and PID) or ceftriaxone
(treatment for VDS and PID if pregnant) were prescribed, 773/
830 (93%) did not have a laboratory diagnosis for N. gonorrhoeae. Of
the visits where metronidazole (treatment for VDS and PID) was
prescribed, 632/782 (81%) did not have a laboratory diagnosis of
T. vaginalis or bacterial vaginosis.
Risk factors for laboratory-diagnosed STIs
Results from multivariate models for each level of the
conceptual framework are shown in Tables S1–S4 in File S1,
with results from the final model at each level reported in Table 3.
Participants who had been working in their facility for a longer
time were less likely to be infected with C. trachomatis (p-
trend= 0.01; Table 3). Age was strongly associated with C.
trachomatis infection, with younger participants being at higher risk
(p-trend= 0.003). Participants who had more reported lifetime sex
partners were more likely to be infected with C. trachomatis
infection (p-trend= 0.005). There was evidence of an association
between C. trachomatis infection and contraception use (p = 0.02);
those using DMPA (adjusted[a]OR 2.21; CI 1.39–3.52) and
condoms only (aOR 1.50; CI 1.01–2.24) were at higher risk
compared to those who reported no contraception use. Partici-
Curable STIs in Northwestern Tanzania
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pants who had at least one pregnancy in their lifetime had twice
the odds of C. trachomatis infection (aOR 1.96; 95% CI 1.10, 3.50)
compared with those who had never been pregnant. C. trachomatis
infection was also associated with N. gonorrhoeae infection (aOR
2.21; CI 1.23–3.97).
Younger women were also at higher risk of N. gonorrhoeae
infection (p-trend,0.001; Table 3). There was some evidence that
harmful or hazardous drinking, compared to no or low-risk
drinking, was associated with N. gonorrhoeae infection (aOR 1.83; CI
1.03, 3.25). Participants who had at least one pregnancy in their
lifetime had more than three times the odds of N. gonorrhoeae
infection (aOR 3.39; CI 1.41, 8.16). N. gonorrhoeae was strongly
associated with C. trachomatis infection (aOR 2.19; CI 1.19, 4.05).
Figure 1. Prevalence of (a) curable sexually transmitted infections, and (b) syndromes diagnosed, by visit month, in a cohort of
women at increased risk for HIV acquisition in northwestern Tanzania. Lighter shaded section of each bar represents those who were
diagnosed by syndromic management. Values shown at the top of the bars are the overall prevalence (%). CT = Chlamydia trachomatis, NG=Neisseria
gonorrhoeae, TV = Trichomonas vaginalis, syph= high-titre active syphilis.
doi:10.1371/journal.pone.0101221.g001
Table 1. Trend in prevalence of laboratory-diagnosed curable sexually transmitted infections and syndromes diagnosed over the
12 month follow-up period in a cohort of women at increased risk for HIV acquisition in northwestern Tanzania.
Prevalence at enrolment (%; 95% CI) OR (95% CI) for linear trend (per month) P-value
Infections
C. trachomatis 111/956 (12%; 10, 14) 0.94 (0.91,0.97) ,0.001
N. gonorrhoeae 42/955 (4%; 3, 6) 0.98 (0.94,1.02) 0.34
T. vaginalis 184/945 (19%; 17, 22) 0.95 (0.93,0.98) ,0.001
Syndromes
Pelvic inflammatory disease 249/966 (26%; 23, 29) 0.85 (0.83,0.88) ,0.001
Vaginal discharge syndrome (without curd-like discharge) 108/966 (11%; 9, 13) 0.91 (0.88,0.94) ,0.001
Vaginal discharge syndrome (with curd-like discharge) 92/966 (10%; 9,12) 0.95 (0.92,0.98) ,0.001
CI = confidence interval; OR = odds ratio.
doi:10.1371/journal.pone.0101221.t001
Curable STIs in Northwestern Tanzania
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Higher education level was associated with lower odds of T.
vaginalis infection (p-trend,0.001; Table 3). Higher T. vaginalis
prevalence was found in divorced, separated or widowed (aOR
2.42; 1.49, 3.93) and single (aOR1.96; 1.08, 3.57) women
compared to married women. Current intermediate vaginal
microbiota (aOR 4.37; 2.84, 6.72) and bacterial vaginosis (aOR
2.28; 1.58, 3.30) were strongly associated with T. vaginalis infection.
There was weak evidence of an association between T. vaginalis
and syphilis (p = 0.08), in particular for active syphilis (aOR 1.85;
1.08, 3.17).
Higher education levels were also associated with lower
prevalence of high-titre active syphilis infection at enrolment
(aOR 0.31; 0.17, 0.57 for those who completed primary school
compared with those who did not; Table 3). Participants who
reported concurrent sex partners in the past three months had
higher odds of high-titre active syphilis (aOR 2.71; 1.39, 5.28). T.
vaginalis infection (aOR 3.27; 1.66, 6.43) was strongly associated
with high-titre active syphilis infection.
Discussion
The prevalences of curable STIs were high indicating that these
infections are a major public health problem among women
working in bars, hotels, and other food and recreational facilities
near large-scale gold and diamond mines in northwestern
Tanzania. Our findings were consistent with previous studies
from similar populations in Tanzania, and indicate continued high
burden of these infections [9,10,12]. T. vaginalis was the most
prevalent infection at enrolment and throughout the study period.
Further, while culture is considered the gold standard for detection
of T. vaginalis, the sensitivity of culture has been reported to be
75% to 89% compared to nucleic acid amplification tests [45,46],
and therefore the prevalence of T. vaginalis in this study population
may be underestimated. T. vaginalis infection has been associated
with pelvic inflammatory disease, endometritis, adverse pregnancy
outcomes, and HIV acquisition [22–25]. There is also evidence
that HIV infection is associated with T. vaginalis acquisition [26]
Therefore, T. vaginalis is an important infection to target in
prevention efforts as this synergy may contribute in continued
expansion of the HIV epidemic in this population [26].
We observed a significant decrease in the prevalence of C.
trachomatis and T. vaginalis over the one-year follow-up period,
consistent with the provision of behavioural counselling, condom
provision and free STI treatment as seen in other studies [12].
However, we did not observe a significant decrease in syphilis
which may reflect a slow decline in RPR titre after treatment, or
serofast reactions in which nontreponemal antibodies persist for a
long period of time [27].
Due to a low sensitivity of syndromic management to detect
laboratory-diagnosed infections in this population at increased risk
for HIV infection, most infections were missed by this approach.
Thus, the majority of these infections would have gone untreated
in a syndromic management setting where laboratory testing was
not routinely done. Poor sensitivity of syndromic management has
been documented in other settings, for example among female sex
workers in India [28]. It is important to note that syndromic STI
management guidelines were not developed as a screening tool for
asymptomatic patients. Nevertheless, in many resource-limited
settings, this is the only STI management tool available – even to
populations at increased risk for STIs and HIV. Furthermore,
many research cohorts rely on syndromic management to treat
STIs in their study populations until laboratory results are
available. The results of this study are a reminder that this
approach will miss a high proportion of cases, and in the interim
period between study visit and laboratory diagnosis, transmission
and sequelae of STIs may occur. Interestingly, a recent study
among sex workers in South Africa has shown that cervicovaginal
inflammatory cytokines did not differ between women with and
without symptoms; and in both groups inflammatory cytokines
were elevated [17]. Previous studies have suggested that elevated
inflammatory cytokines may facilitate HIV transmission [29], and,
thus, women with asymptomatic STIs may be as susceptible to
HIV infection as those with symptoms.
This study also revealed the poor PPV of syndromic manage-
ment, and as a consequence, a high proportion of participants in
our study were given antibiotics that they did not need. In addition
to the costs associated with over-treatment of STIs in a resource-
limited setting, over-use of antibiotics is a major concern as
resistance to N. gonorrhoeae has become widespread [30,31] and
there is evidence of fluoroquinolone resistance in East Africa
Figure 2. Prevalence of syndromes diagnosed, by visit month, in a cohort of women at increased risk for HIV acquisition in
northwestern Tanzania. Values shown at the top of the bars are the prevalence (%). PID =pelvic inflammatory disease, VDS= vaginal discharge
syndrome.
doi:10.1371/journal.pone.0101221.g002
Curable STIs in Northwestern Tanzania
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[32,33]. Furthermore, the first line treatment for N. gonorrhoeae in
the Tanzanian Ministry of Health guidelines is ciprofloxacin.
Research is urgently needed to evaluate fluoroquinolone resistance
to N. gonorrhoeae in northwestern Tanzania. Although we found a
relatively low prevalence of N. gonorrhoeae in our study, we found no
evidence of a decrease in N. gonorrhoeae over the follow-up period,
and this may have been due to treatment resistance. An important
caveat is that while C. trachomatis, N. gonorrhoeae and bacterial
vaginosis are found in some cases of PID, the infectious cause of
PID is often unknown[34]; therefore, the absence of these
pathogens does not necessarily signify the absence of PID, and
does not indicate that treatment was not needed. Overall, our
findings show that syndromic management is not effective for
controlling STIs in this population at increased risk of HIV
infection, and there is an urgent need to develop focused
interventions and programmes to prevent, identify and treat STIs
effectively in this population.
Our risk factor analysis identified women at greatest risk for
STIs in this population and who may benefit from focused
interventions. Young women were at increased risk for C.
trachomatis and N. gonorrhoeae infection, and these infections were
associated with each other. Lower levels of education were a risk
factor for both T. vaginalis and high-titre active syphilis, and these
infections were associated with each other. Married women were
at lower risk of T. vaginalis. Sexual and other behavioural indices,
such as higher total number of lifetime partners, concurrent sex
partners and harmful alcohol use were associated with curable
STIs. Overall, risk factors for curable STIs identified in this cohort
were as expected and consistent with the literature [35–38]. One
exception was the finding that women who had at least one
pregnancy in their lifetime were at higher risk for C. trachomatis and
N. gonorrhoeae infection; it is possible that a past pregnancy may be a
proxy for past unprotected sex. Additionally, women who had
recently started work in a recreational or food facility were at
higher risk for C. trachomatis infection than those who had been
there for a year or more. There is evidence suggesting partial
immunity against reinfection with C. trachomatis [39]; therefore
women entering into a high risk occupation may be at higher risk
of infection than those who have been working in a high-risk
setting for several years. It is also possible that some behaviour
change may account for this difference, with women who have
been working in a facility for a longer time possibly having fewer
sexual partners or using condoms more often; however we found
no evidence for this in this cohort.
Women in this study using DMPA were at higher risk for C.
trachomatis infection. Several longitudinal studies have found an
association between DMPA use and cervical infection with either
C. trachomatis or N. gonorrhoeae [40–42], as well as HIV acquisition
[43], although these findings have not been consistent [44]. While
C. trachomatis may lie on the causal pathway between DMPA and
HIV acquisition, DMPA may also increase susceptibility to both
infections. It is also possible that women who use DMPA may have
different sexual behaviour (e.g. use less condoms) than those who
do not use DMPA, which may increase risk for STIs. Indeed,
women using hormonal contraceptives have been shown to use
condoms less frequently than women not using hormonal
contraception [42].
The foundation of STI prevention and control is early diagnosis
and treatment, including the treatment of partners. Yet, sensitive
screening tests for STIs are expensive and rarely available in
resource-limited settings. Affordable, rapid point-of-care tests
would be valuable tools for detection and treatment of these
infections in this population, and should be a priority for
development [47]. A modelling study using data from a sex
worker project in Benin suggested that rapid point-of-care
screening tests for cervical infection due to C. trachomatis and N.
gonorrhoeae may be more cost effective than a syndromic approach
because of higher sensitivity and specificity [48]. Of the potential
interventions available, there is good evidence that risk reduction
counselling and condom promotion reduce STI risk [49].
Structural interventions, such as economic interventions or
tackling gender disadvantage, are promising interventions to
address main underlying factors in this population, but are not
well evaluated [49].
In summary, we found a high prevalence of STIs among women
who work in bars, hotels, and other food and recreational facilities
near large-scale gold and diamond mines in northwestern
Tanzania. This population is at increased risk for HIV infection
in addition to reproductive health morbidities caused by STIs.
Syndromic diagnosis, dependent on signs and symptoms of STIs,
was poorly predictive of laboratory-diagnosed STIs. Untreated
STIs in this population will translate into a high risk of STIs for
male partners, sexual partners of those men, and infants who may
become congenitally infected. The importance of the treatment
errors and missed opportunities for cure should not be under-
estimated. Innovative strategies to reduce the burden of STIs are
urgently needed, and affordable rapid-point-of-care tests should be
a priority for development.
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